Table 1

Characteristics of randomised controlled trials included in the study

CharacteristicAccepted by The BMJ
n (%)
Rejected by The BMJ
n (%)
Trial design
 Parallel16(76)17(81)
 Cluster4(19)3(14)
 Cross-over0(0)1(5)
 Factorial1(5)0(0)
Multicentre/single centre
 Multicentre18(86)15(71)
 Single centre3(14)6(29)
Trial sample size
 <1001(5)4(19)
 100–99914(67)13(62)
 >10006(29)4(19)
Duration of trial (follow-up)
 <12 months8(38)10(48)
 12 to 24 months12(57)9(43)
 >24 months1(5)1(5)
 Unclear0(0)1(5)
Location of lead investigator
 UK10(48)6(29)
 Rest of Europe6(29)5(24)
 North America0(0)1(5)
 Rest of World5(24)9(43)
Source of funding
 Commercial0(0)0(0)
 Non-commercial15(71)18(86)
 Both5(24)3(14)
 Not stated1(5)0(0)
Trial registration
 Yes21(100)21(100)
 No0(0)0(0)
Where was the trial registered
 Clinical trials.gov2(10)6(29)
 ISRCTN Register16(76)9(43)
 Australian/New Zealand CTR1(5)5(24)
 Dutch Trial Register2(10)0(0)
 UMIN CTR0(0)1(5)
Prospective/retrospective registered
 Prospective19(91)10(48)
 Retrospective1*(5)10(48)
 Unclear†1(5)1(5)
Published protocol
 Yes14(67)11(52)
 No7(33)10(48)
Where was the protocol published: (n=14 accepted, n=11 rejected)
 BMC series13(93)10(91)
 Other1‡(7)(9)
  • *Study started March 1999, prior to ICMJE trial registration recommendation.

  • †Exact date first participant recruited into trial not provided.

  • ‡Published in Contemporary Clinical Trials.

  • §Published in Journal of Foot and Ankle Research.

  • BMC, BioMed Central; CTR, Clinical Trial Registry; ICMJE, International Committee of Medical Journal Editors; ISRCTN, International Standard Randomised Controlled Trials Number; UMIN, University Hospital Medical Information Network.